Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

PHR

Phreesia Inc

Mar 20 • 04:00PM ET

27.61

Dollar change -1.39
Percentage change -4.79	%

Healthcare • Health Information Services • USA • NYSE

Peers: VEEV UNH TDOC EVH GEHC ADP MASI BLKB HIMS HSTM

| Held by: VTI IWM VXF VB IWO VBK SCHA VTWO FESM VHT

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-1.02	Insider Own	8.50%	Shs Outstand	58.73M	Perf Week	8.49%
Market Cap	1.62B	Forward P/E	128.03	EPS next Y	0.22	Insider Trans	-7.40%	Shs Float	53.78M	Perf Month	-6.97%
Income	-58.53M	PEG	-	EPS next Q	-0.11	Inst Own	92.97%	Short Float	3.84%	Perf Quarter	7.68%
Sales	419.81M	P/S	3.87	EPS this Y	76.18%	Inst Trans	-1.19%	Short Ratio	4.76	Perf Half Y	13.11%
Book/sh	4.51	P/B	6.12	EPS next Y	188.75%	ROA	-15.41%	Short Interest	2.06M	Perf Year	20.36%
Cash/sh	1.43	P/C	19.27	EPS next 5Y	-	ROE	-22.67%	52W Range	17.07 - 30.53	Perf YTD	9.74%
Dividend Est.	-	P/FCF	68.99	EPS past 5Y	16.05%	ROI	-21.39%	52W High	-9.56%	Beta	0.77
Dividend TTM	-	Quick Ratio	1.78	Sales past 5Y	27.79%	Gross Margin	60.78%	52W Low	61.75%	ATR (14)	1.42
Dividend Ex-Date	-	Current Ratio	1.78	EPS Y/Y TTM	59.64%	Oper. Margin	-13.84%	RSI (14)	55.23	Volatility	5.80% 5.56%
Employees	2082	Debt/Eq	0.07	Sales Y/Y TTM	17.83%	Profit Margin	-13.94%	Recom	1.13	Target Price	32.29
Option/Short	Yes / Yes	LT Debt/Eq	0.03	EPS Q/Q	80.49%	Payout	-	Rel Volume	1.49	Prev Close	29.00
Sales Surprise	0.71%	EPS Surprise	38.17%	Sales Q/Q	15.45%	Earnings	Mar 12 AMC	Avg Volume	433.64K	Price	27.61
SMA20	6.60%	SMA50	1.23%	SMA200	17.76%	Trades		Volume	648,260	Change	-4.79%

Date	Action	Analyst	Rating Change	Price Target Change
Jan-08-25	Upgrade	RBC Capital Mkts	Sector Perform → Outperform	$24 → $32
Feb-26-24	Initiated	Truist	Buy	$35
Jan-17-24	Upgrade	DA Davidson	Neutral → Buy	$30 → $32
Jan-03-24	Initiated	Barclays	Overweight	$29
Apr-12-23	Initiated	Stephens	Overweight	$37
Jan-04-23	Reiterated	Needham	Buy	$35 → $40
Dec-13-22	Upgrade	Citigroup	Neutral → Buy	$40
Dec-09-22	Upgrade	SVB Leerink	Mkt Perform → Outperform	$31 → $34
Oct-13-22	Initiated	DA Davidson	Neutral	$25
Sep-16-22	Initiated	KeyBanc Capital Markets	Overweight	$40
Apr-14-22	Initiated	Guggenheim	Buy	$45
Jan-06-22	Downgrade	SVB Leerink	Outperform → Mkt Perform	$57 → $41
Dec-02-21	Initiated	Jefferies	Buy	$70
Sep-02-21	Reiterated	Needham	Buy	$70 → $81
Aug-27-21	Initiated	Canaccord Genuity	Buy	$81
Jul-13-21	Initiated	JMP Securities	Mkt Outperform	$80
Jun-08-21	Initiated	Berenberg	Buy	$70
Apr-29-21	Resumed	JP Morgan	Overweight	$64
Apr-01-21	Initiated	Robert W. Baird	Outperform	$60
Nov-11-20	Initiated	Stephens	Overweight	$50

Show Previous Ratings

Mar-19-25 09:03AM	1 Small-Cap Stock with Solid Fundamentals and 2 to Ignore (StockStory) +6.34%
Mar-14-25 05:02AM	Q4 Earnings Review: Healthcare Technology for Providers Stocks Led by Phreesia (NYSE:PHR) (StockStory)
Mar-13-25 04:06PM	Phreesia Named to G2s List of 2025 Best Healthcare Software Products (Business Wire) +6.93%
07:30AM	Q4 2025 Phreesia Inc Earnings Call (Thomson Reuters StreetEvents)
03:09AM	Phreesia Inc (PHR) Q4 2025 Earnings Call Highlights: Strong Revenue Growth and Positive Cash Flow (GuruFocus.com)
05:30PM	Loading…
Mar-12-25 05:30PM	Phreesia (PHR) Reports Q4 Earnings: What Key Metrics Have to Say (Zacks)
05:15PM	Phreesia (PHR) Reports Q4 Loss, Tops Revenue Estimates (Zacks)
04:40PM	Phreesia (NYSE:PHR) Posts Better-Than-Expected Sales In Q4 But Stock Drops (StockStory)
04:17PM	Phreesia: Fiscal Q4 Earnings Snapshot (Associated Press Finance)
04:03PM	Phreesia Announces Fourth Quarter Fiscal 2025 Results (Business Wire)
Mar-11-25 08:02AM	Phreesia (PHR) To Report Earnings Tomorrow: Here Is What To Expect (StockStory) +5.74%
Feb-14-25 07:02AM	Phreesia (PHR) Moves 5.6% Higher: Will This Strength Last? (Zacks)
Feb-11-25 01:45PM	Why Insiders Are Selling Phreesia, Inc. (PHR) Recently (Insider Monkey)
06:48AM	Phreesias Sally Thayer Selected as a Top Woman Leader in Software (Business Wire)
Feb-07-25 04:15PM	Phreesia Sets Release Date for Fiscal Fourth Quarter and Fiscal Year 2025 Results (Business Wire)
09:15AM	Loading…
Jan-29-25 09:15AM	Phreesia, Inc. (PHR) Soars to 52-Week High, Time to Cash Out? (Zacks)
Jan-14-25 12:00PM	Phreesia (PHR) Upgraded to Buy: Here's Why (Zacks)
Jan-08-25 09:55AM	Should You Buy Phreesia (PHR) After Golden Cross? (Zacks) +5.37%
Dec-20-24 09:55AM	Wall Street Analysts See a 25% Upside in Phreesia (PHR): Can the Stock Really Move This High? (Zacks) +5.54%
Dec-12-24 07:17AM	Phreesia price target lowered to $30 from $34 at Baird (TipRanks)
Dec-10-24 08:13AM	Q3 2025 Phreesia Inc Earnings Call (Thomson Reuters StreetEvents) +11.60%
02:01AM	Phreesia Inc (PHR) Q3 2025 Earnings Call Highlights: Strong Revenue Growth and Positive Cash Flow (GuruFocus.com)
Dec-09-24 06:00PM	Phreesia (PHR) Reports Q3 Earnings: What Key Metrics Have to Say (Zacks)
05:20PM	Phreesia (PHR) Reports Q3 Loss, Tops Revenue Estimates (Zacks)
04:21PM	Phreesia: Fiscal Q3 Earnings Snapshot (Associated Press Finance)
04:05PM	Phreesia Announces Third Quarter Fiscal 2025 Results (Business Wire)
Dec-06-24 09:15AM	Curious about Phreesia (PHR) Q3 Performance? Explore Wall Street Estimates for Key Metrics (Zacks)
Nov-22-24 06:48AM	Phreesia Named to The Software Reports Top 100 Software Companies for the Third Consecutive Year (Business Wire)
Nov-07-24 04:26AM	Phreesia (PHR) Moves 13.9% Higher: Will This Strength Last? (Zacks)
Nov-01-24 06:48AM	Phreesia Sets Release Date for Fiscal Third Quarter 2025 Results (Business Wire)
06:48AM	Loading…
Oct-28-24 06:48AM	Phreesia Achieves Oracle Validated Integration With Oracle Health EHR Expertise for Delivering Proven, Repeatable Integration (Business Wire)
Oct-11-24 12:14PM	Is Phreesia, Inc. (NYSE:PHR) The Top Stock With Improving Technical Ratings According To Piper Sandler? (Insider Monkey)
Oct-10-24 09:35AM	Down -10.25% in 4 Weeks, Here's Why Phreesia (PHR) Looks Ripe for a Turnaround (Zacks)
Oct-08-24 06:48AM	Phreesia Joins the Network Advertising Initiative as a Member, Demonstrating Ongoing Commitment to Industry-Leading Privacy Practices (Business Wire)
Oct-03-24 06:48AM	Phreesia and Ad Council Partnership Yields High Patient Engagement in 3 Mental Health Awareness Campaigns (Business Wire)
Oct-01-24 06:48AM	Phreesia Secures New Contract With CMS as Report Shows Gains in Patient Activation in First Year of Kidney Care Choices (KCC) Model (Business Wire)
Sep-19-24 06:48AM	New Research Shows Point-of-Care Patient Outreach Supports Vaccine Confidence and Adoption (Business Wire)
Sep-17-24 04:28PM	CDC Awards Grant to NAFC, Phreesia and Health.Equity.Outcomes. to Tackle Public Health Challenge of Urinary Incontinence (Business Wire)
Sep-05-24 12:39PM	Q2 2025 Phreesia Inc Earnings Call (Thomson Reuters StreetEvents) +6.29%
Sep-04-24 06:00PM	Phreesia (PHR) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates (Zacks)
05:15PM	Phreesia (PHR) Reports Q2 Loss, Tops Revenue Estimates (Zacks)
04:15PM	Phreesia: Fiscal Q2 Earnings Snapshot (Associated Press Finance)
04:03PM	Phreesia Announces Second Quarter Fiscal 2025 Results (Business Wire)
Sep-03-24 09:03AM	Earnings To Watch: Phreesia Inc (PHR) Reports Q2 2025 Result (GuruFocus.com) -7.43%
Aug-29-24 09:15AM	Phreesia (PHR) Q2 Earnings on the Horizon: Analysts' Insights on Key Performance Measures (Zacks)
06:48AM	Phreesia and American Academy of Pediatrics Join in Campaign to Increase Childhood MMR Vaccination (Business Wire)
Aug-08-24 06:48AM	Bob Glazer Joins Phreesia as Strategic Advisor (Business Wire)
Aug-05-24 09:00PM	Bragar Eagel & Squire, P.C. Is Investigating Helen of Troy, Owens & Minor, Salesforce, and Phreesia and Encourages Investors to Contact the Firm (GlobeNewswire)
Aug-01-24 06:48AM	Phreesia Sets Release Date for Fiscal Second Quarter 2025 Results (Business Wire)
Jul-30-24 06:48AM	Phreesia Now Available on Oracle Healthcare Marketplace (Business Wire)
Jul-19-24 09:55AM	Wall Street Analysts Think Phreesia (PHR) Could Surge 27.77%: Read This Before Placing a Bet (Zacks)
Jul-12-24 12:00PM	Phreesia (PHR) Upgraded to Strong Buy: Here's What You Should Know (Zacks)
Jun-10-24 10:26AM	New Research Illustrates How to Drive Earlier Diagnosis and Treatment of Kidney Disease (Business Wire)
Jun-04-24 09:35AM	Here's Why Phreesia (PHR) is Poised for a Turnaround After Losing -18.25% in 4 Weeks (Zacks)
May-31-24 11:59AM	Q1 2025 Phreesia Inc Earnings Call (Thomson Reuters StreetEvents) -11.22%
May-30-24 08:54PM	PHR Stock Earnings: Phreesia Beats EPS, Beats Revenue for Q1 2025 (InvestorPlace)
05:30PM	Compared to Estimates, Phreesia (PHR) Q1 Earnings: A Look at Key Metrics (Zacks)
05:15PM	Phreesia (PHR) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
04:08PM	Phreesia: Fiscal Q1 Earnings Snapshot (Associated Press Finance)
04:03PM	Phreesia Announces First Quarter Fiscal 2025 Results (Business Wire)
May-28-24 06:48AM	Phreesia Joins the MEDITECH Alliance Program as an Innovator Partner (Business Wire)
May-24-24 09:15AM	Unlocking Q1 Potential of Phreesia (PHR): Exploring Wall Street Estimates for Key Metrics (Zacks)
May-23-24 04:30PM	Phreesias Amy Patel Named One of PM360s 2024 ELITE 100 (Business Wire)
May-21-24 04:30PM	Phreesia Named as One of Modern Healthcares Best Places to Work in Healthcare for the Eighth Time (Business Wire)
May-01-24 06:46AM	Phreesias Alicia Cowley and Natasha Vega Named to MM+Ms Women to Watch for 2024 (Business Wire)
Apr-29-24 06:48AM	Phreesia Sets Release Date for Fiscal First Quarter 2025 Results (Business Wire)
Mar-25-24 07:01PM	Insider Sell: COO Evan Roberts Sells 25,962 Shares of Phreesia Inc (PHR) (GuruFocus.com)
Mar-19-24 06:48AM	Phreesia Announces Jack Callahan as New Chief Technology Officer (Business Wire)
Mar-17-24 10:22AM	Phreesia, Inc. (NYSE:PHR) Q4 2024 Earnings Call Transcript (Insider Monkey)
Mar-15-24 06:56AM	Q4 2024 Phreesia Inc Earnings Call (Thomson Reuters StreetEvents)
Mar-14-24 08:55PM	PHR Stock Earnings: Phreesia Misses EPS, Beats Revenue for Q4 2024 (InvestorPlace)
06:00PM	Phreesia (PHR) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates (Zacks)
05:25PM	Phreesia (PHR) Reports Q4 Loss, Tops Revenue Estimates (Zacks)
04:22PM	Phreesia: Fiscal Q4 Earnings Snapshot (Associated Press Finance)
04:03PM	Phreesia Announces Fourth Quarter Fiscal 2024 Results (Business Wire)
Mar-07-24 10:00AM	Will Phreesia (PHR) Report Negative Earnings Next Week? What You Should Know (Zacks)
Feb-27-24 04:05PM	Phreesias Hilary Hatch Again Named to the 2024-2025 NQF Leadership Consortium (Business Wire)
Feb-20-24 06:48AM	New Data Shows That Engaging Patients with Relevant Cancer-Prevention Information During Check-In Increases Screening Rates (Business Wire) -6.32%
Feb-19-24 11:53AM	Phreesia (PHR) Rose on 2024 Guidance (Insider Monkey)
Feb-05-24 04:05PM	Phreesia Sets Release Date for Fiscal Fourth Quarter 2024 Results (Business Wire)
06:54AM	Bull Of The Day: Phreesia (PHR) (Zacks)
Jan-23-24 06:40AM	Phreesia Joins Call to Action to Improve Adult Vaccination Rates (Business Wire)
Jan-18-24 07:59PM	Phreesia Inc CFO Balaji Gandhi Sells 10,124 Shares (GuruFocus.com)
Jan-16-24 04:05PM	Phreesias Audrey Gato Named as a Top Woman Leader in SaaS (Business Wire)
Jan-11-24 06:44AM	Phreesias Post-Script Engagement named one of PM360s 2023 Most Innovative Technologies (Business Wire)
Dec-27-23 09:55AM	Does Phreesia (PHR) Have the Potential to Rally 30.09% as Wall Street Analysts Expect? (Zacks)
08:06AM	What Caused a -40% Drop in Phreesia (PHR) Shares? (Insider Monkey)
Dec-11-23 09:55AM	Wall Street Analysts Predict a 77.77% Upside in Phreesia (PHR): Here's What You Should Know (Zacks)
Dec-08-23 08:21AM	Phreesia, Inc. (NYSE:PHR) Q3 2024 Earnings Call Transcript (Insider Monkey)
Dec-06-23 10:37AM	Q3 2024 Phreesia Inc Earnings Call (Thomson Reuters StreetEvents) +21.22%
Dec-05-23 06:00PM	Here's What Key Metrics Tell Us About Phreesia (PHR) Q3 Earnings (Zacks)
05:40PM	Phreesia Inc (PHR) Reports Revenue Growth and Narrowed Net Loss in Q3 Fiscal 2024 (GuruFocus.com)
05:15PM	Phreesia (PHR) Reports Q3 Loss, Tops Revenue Estimates (Zacks)
04:17PM	Phreesia: Fiscal Q3 Earnings Snapshot (Associated Press Finance)
04:03PM	Phreesia Announces Third Quarter Fiscal 2024 Results (Business Wire)
Dec-01-23 06:00AM	CMS Includes the Patient Activation Measure in its Merit-Based Incentive Payment System Starting in 2024 (Business Wire)
Nov-16-23 03:12AM	Here's Why Phreesia (PHR) Declined in Q3 (Insider Monkey)
Nov-08-23 06:00AM	Phreesia Achieves HITRUST Risk-Based, 2-Year Certification Demonstrating the Highest Level of Information Protection Assurance (Business Wire)
Nov-01-23 09:12AM	Phreesia (PHR) Surges 10.3%: Is This an Indication of Further Gains? (Zacks)
06:03AM	Phreesia Sets Release Date for Fiscal Third Quarter 2024 Results (Business Wire)

Phreesia, Inc. engages in the provision of patient check-in solutions for medical practices. The firm offers appointments, clinical support, integration, registration, patient activation, analytics and reports, revenue cycle, patient surveys, and privacy and security products. Its solutions include health systems, multi-specialty, and federally qualified health centers (FQHCs). The company was founded by Chaim Indig and Evan Roberts in January 2005 and is headquartered in Wilmington, DE.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Linetsky David	SVP, Life Sciences	Mar 19 '25	Sale	27.88	88	2,454	8,724	Mar 20 05:01 PM
Linetsky David	SVP, Life Sciences	Mar 18 '25	Sale	26.95	39	1,051	8,812	Mar 20 05:01 PM
Hoffman Allison C	General Counsel & Secretary	Mar 17 '25	Sale	25.32	3,496	88,519	139,134	Mar 19 05:20 PM
Linetsky David	Member of immediate family of	Mar 19 '25	Proposed Sale	27.89	88	2,454		Mar 19 03:32 PM
Linetsky David	Member of immediate family of	Mar 18 '25	Proposed Sale	26.95	39	1,051		Mar 18 03:15 PM
Hoffman Allison C	Officer	Mar 17 '25	Proposed Sale	25.32	3,496	88,519		Mar 17 09:54 AM
Roberts Evan	Chief Operating Officer	Feb 18 '25	Sale	30.06	3,519	105,764	741,197	Feb 20 04:49 PM
Roberts Evan	Chief Operating Officer	Feb 19 '25	Sale	30.00	177	5,310	741,020	Feb 20 04:49 PM
Gandhi Balaji	Chief Financial Officer	Feb 18 '25	Sale	30.04	5,771	173,377	105,514	Feb 20 04:48 PM
Gandhi Balaji	Chief Financial Officer	Feb 19 '25	Sale	30.00	96	2,880	105,418	Feb 20 04:48 PM
Hoffman Allison C	General Counsel & Secretary	Feb 18 '25	Sale	29.72	3,496	103,901	142,630	Feb 20 04:47 PM
Gandhi Balaji	Officer	Feb 19 '25	Proposed Sale	30.00	96	2,880		Feb 19 04:41 PM
Roberts Evan	Officer	Feb 19 '25	Proposed Sale	30.00	177	5,310		Feb 19 04:01 PM
Roberts Evan	Chief Operating Officer	Feb 13 '25	Sale	30.00	16,005	480,152	748,302	Feb 18 04:38 PM
Roberts Evan	Chief Operating Officer	Feb 14 '25	Sale	30.13	3,586	108,039	744,716	Feb 18 04:38 PM
Gandhi Balaji	Chief Financial Officer	Feb 13 '25	Sale	30.00	28,759	862,770	116,174	Feb 18 04:36 PM
Gandhi Balaji	Chief Financial Officer	Feb 14 '25	Sale	30.09	4,889	147,088	111,285	Feb 18 04:36 PM
Linetsky David	SVP, Life Sciences	Feb 13 '25	Sale	29.70	11,616	345,001	218,135	Feb 18 04:35 PM
Gandhi Balaji	Officer	Feb 18 '25	Proposed Sale	30.04	5,771	173,377		Feb 18 04:33 PM
Roberts Evan	Officer	Feb 18 '25	Proposed Sale	30.06	3,519	105,764		Feb 18 04:15 PM
Hoffman Allison C	Officer	Feb 18 '25	Proposed Sale	29.72	3,496	103,901		Feb 18 10:16 AM
Gandhi Balaji	Officer	Feb 14 '25	Proposed Sale	30.09	4,889	147,089		Feb 14 04:31 PM
Roberts Evan	Officer	Feb 14 '25	Proposed Sale	30.13	3,586	108,039		Feb 14 04:26 PM
Gandhi Balaji	Officer	Feb 13 '25	Proposed Sale	30.00	28,759	862,770		Feb 13 05:17 PM
Roberts Evan	Officer	Feb 13 '25	Proposed Sale	30.00	16,005	480,152		Feb 13 04:58 PM
Linetsky David	Officer	Feb 13 '25	Proposed Sale	29.70	11,616	345,001		Feb 13 04:24 PM
Linetsky David	SVP, Life Sciences	Feb 07 '25	Sale	29.52	300	8,857	229,751	Feb 11 06:16 PM
Linetsky David	SVP, Life Sciences	Feb 05 '25	Sale	29.50	720	21,241	230,051	Feb 07 04:51 PM
Linetsky David	Officer	Feb 07 '25	Proposed Sale	29.52	300	8,857		Feb 07 04:28 PM
Linetsky David	Officer	Feb 05 '25	Proposed Sale	29.50	720	21,241		Feb 05 04:13 PM
Linetsky David	SVP, Life Sciences	Jan 29 '25	Sale	29.68	500	14,841	230,771	Jan 31 04:23 PM
Gandhi Balaji	Chief Financial Officer	Jan 27 '25	Sale	27.48	4,813	132,244	144,933	Jan 29 04:52 PM
Hoffman Allison C	General Counsel & Secretary	Jan 27 '25	Sale	27.48	6,556	180,135	152,361	Jan 29 04:50 PM
Hoffman Allison C	General Counsel & Secretary	Jan 28 '25	Sale	28.50	6,235	177,698	146,126	Jan 29 04:50 PM
Linetsky David	SVP, Life Sciences	Jan 27 '25	Sale	27.48	11,685	321,060	231,271	Jan 29 04:47 PM
Roberts Evan	Chief Operating Officer	Jan 27 '25	Sale	27.48	10,716	294,436	764,307	Jan 29 04:46 PM
Indig Chaim	Chief Executive Officer	Jan 27 '25	Sale	27.48	26,248	721,198	1,260,200	Jan 29 04:45 PM
VanDuyn Amy Beth	SVP, Human Resources	Jan 27 '25	Sale	27.48	3,475	95,480	114,734	Jan 29 04:40 PM
Linetsky David	Officer	Jan 29 '25	Proposed Sale	29.68	500	14,841		Jan 29 04:25 PM
Hoffman Allison C	Officer	Jan 28 '25	Proposed Sale	28.50	6,235	177,698		Jan 28 12:13 PM
Hoffman Allison C	Officer	Jan 27 '25	Proposed Sale	27.48	6,556	180,135		Jan 27 04:35 PM
Hui Yvonne	Principal Accounting Officer	Jan 24 '25	Sale	28.00	127	3,556	25,647	Jan 27 04:30 PM
Linetsky David	Officer	Jan 27 '25	Proposed Sale	27.48	11,685	321,061		Jan 27 04:30 PM
Roberts Evan	Officer	Jan 27 '25	Proposed Sale	27.48	10,716	294,436		Jan 27 04:24 PM
VanDuyn Amy Beth	Officer	Jan 27 '25	Proposed Sale	27.48	3,475	95,480		Jan 27 04:20 PM
Indig Chaim	Officer	Jan 27 '25	Proposed Sale	27.48	26,248	721,198		Jan 27 04:14 PM
Gandhi Balaji	Officer	Jan 27 '25	Proposed Sale	27.48	4,813	132,243		Jan 27 04:13 PM
Hui Yvonne	Officer	Jan 24 '25	Proposed Sale	28.00	127	3,556		Jan 24 03:46 PM
Gandhi Balaji	Chief Financial Officer	Jan 21 '25	Sale	27.31	5,827	159,139	141,846	Jan 22 05:20 PM
Hoffman Allison C	General Counsel & Secretary	Jan 21 '25	Sale	27.31	8,426	230,120	146,126	Jan 22 05:17 PM
Roberts Evan	Chief Operating Officer	Jan 21 '25	Sale	27.31	12,749	348,184	755,459	Jan 22 05:08 PM
VanDuyn Amy Beth	SVP, Human Resources	Jan 21 '25	Sale	27.31	4,720	128,907	110,309	Jan 22 05:02 PM
Linetsky David	SVP, Life Sciences	Jan 21 '25	Sale	27.31	13,873	378,881	223,392	Jan 22 04:59 PM
Indig Chaim	Chief Executive Officer	Jan 21 '25	Sale	27.31	21,692	592,424	1,237,538	Jan 22 04:56 PM
Indig Chaim	Officer	Jan 21 '25	Proposed Sale	27.31	21,692	592,424		Jan 21 04:47 PM
Linetsky David	Officer	Jan 21 '25	Proposed Sale	27.31	13,873	378,881		Jan 21 04:42 PM
Hoffman Allison C	Officer	Jan 21 '25	Proposed Sale	27.31	8,426	230,120		Jan 21 04:31 PM
Roberts Evan	Officer	Jan 21 '25	Proposed Sale	27.31	12,749	348,184		Jan 21 04:30 PM
VanDuyn Amy Beth	Officer	Jan 21 '25	Proposed Sale	27.31	4,720	128,906		Jan 21 04:23 PM
Gandhi Balaji	Officer	Jan 21 '25	Proposed Sale	27.31	5,827	159,139		Jan 21 04:14 PM
Hoffman Allison C	General Counsel & Secretary	Jan 15 '25	Sale	26.90	4,585	123,320	154,552	Jan 17 06:10 PM
Indig Chaim	Chief Executive Officer	Jan 15 '25	Sale	26.98	2,990	80,674	1,259,230	Jan 17 06:08 PM
VanDuyn Amy Beth	SVP, Human Resources	Jan 15 '25	Sale	26.98	604	16,297	115,029	Jan 17 06:06 PM
Hui Yvonne	Principal Accounting Officer	Jan 15 '25	Sale	26.87	381	10,237	25,774	Jan 17 06:05 PM
Linetsky David	SVP, Life Sciences	Jan 15 '25	Sale	26.98	1,946	52,506	237,265	Jan 17 06:03 PM
Roberts Evan	Chief Operating Officer	Jan 15 '25	Sale	26.98	1,785	48,162	768,208	Jan 17 06:02 PM
Gandhi Balaji	Chief Financial Officer	Jan 15 '25	Sale	26.98	836	22,556	147,673	Jan 17 06:00 PM
Hui Yvonne	Principal Accounting Officer	Jan 14 '25	Sale	26.38	362	9,548	26,155	Jan 16 04:14 PM
Hui Yvonne	Officer	Jan 15 '25	Proposed Sale	26.87	381	10,237		Jan 15 04:03 PM
Linetsky David	Officer	Jan 15 '25	Proposed Sale	26.98	1,946	52,506		Jan 15 03:27 PM
VanDuyn Amy Beth	Officer	Jan 15 '25	Proposed Sale	26.98	604	16,297		Jan 15 03:17 PM
Indig Chaim	Officer	Jan 15 '25	Proposed Sale	26.98	2,990	80,674		Jan 15 03:16 PM
Roberts Evan	Officer	Jan 15 '25	Proposed Sale	26.98	1,785	48,162		Jan 15 03:15 PM
Gandhi Balaji	Officer	Jan 15 '25	Proposed Sale	26.98	836	22,556		Jan 15 03:12 PM
Hoffman Allison C	Officer	Jan 15 '25	Proposed Sale	26.98	1,089	29,383		Jan 15 03:08 PM
Hoffman Allison C	Officer	Jan 15 '25	Proposed Sale	26.87	3,496	93,938		Jan 15 10:59 AM
Hui Yvonne	Officer	Jan 14 '25	Proposed Sale	26.38	362	9,548		Jan 14 03:16 PM
Hui Yvonne	Principal Accounting Officer	Jan 10 '25	Sale	27.85	388	10,806	26,517	Jan 13 05:50 PM
Roberts Evan	Chief Operating Officer	Jan 08 '25	Sale	27.95	2,681	74,940	769,993	Jan 10 04:30 PM
Hui Yvonne	Principal Accounting Officer	Jan 08 '25	Sale	28.00	288	8,064	26,905	Jan 10 04:28 PM
Hui Yvonne	Officer	Jan 10 '25	Proposed Sale	27.85	388	10,806		Jan 10 10:40 AM
Roberts Evan	Chief Operating Officer	Jan 07 '25	Sale	27.00	7,319	197,613	772,674	Jan 08 05:28 PM
Roberts Evan	Chief Operating Officer	Jan 06 '25	Sale	26.61	2,873	76,438	779,993	Jan 08 05:28 PM
Gandhi Balaji	Chief Financial Officer	Jan 06 '25	Sale	26.61	3,195	85,005	148,509	Jan 08 05:26 PM
VanDuyn Amy Beth	SVP, Human Resources	Jan 06 '25	Sale	26.61	1,311	34,880	115,633	Jan 08 05:24 PM
Indig Chaim	Chief Executive Officer	Jan 06 '25	Sale	26.61	5,375	143,005	1,262,220	Jan 08 05:23 PM
Hoffman Allison C	General Counsel & Secretary	Jan 06 '25	Sale	26.61	3,982	105,943	159,137	Jan 08 05:22 PM
Linetsky David	SVP, Life Sciences	Jan 06 '25	Sale	26.61	3,133	83,355	239,211	Jan 08 05:21 PM
Roberts Evan	Officer	Jan 08 '25	Proposed Sale	27.95	2,681	74,940		Jan 08 04:12 PM
Hui Yvonne	Officer	Jan 08 '25	Proposed Sale	28.00	288	8,064		Jan 08 10:58 AM
Roberts Evan	Officer	Jan 07 '25	Proposed Sale	27.00	7,319	197,613		Jan 07 04:18 PM
Linetsky David	Officer	Jan 06 '25	Proposed Sale	26.61	3,133	83,355		Jan 06 04:19 PM
Indig Chaim	Officer	Jan 06 '25	Proposed Sale	26.61	5,375	143,005		Jan 06 04:18 PM
Roberts Evan	Officer	Jan 06 '25	Proposed Sale	26.61	2,873	76,438		Jan 06 04:15 PM
VanDuyn Amy Beth	Officer	Jan 06 '25	Proposed Sale	26.61	1,311	34,880		Jan 06 04:05 PM
Gandhi Balaji	Officer	Jan 06 '25	Proposed Sale	26.61	3,195	85,005		Jan 06 03:56 PM
Hoffman Allison C	Officer	Jan 06 '25	Proposed Sale	26.61	3,982	105,943		Jan 06 03:56 PM
Hoffman Allison C	General Counsel & Secretary	Dec 18 '24	Sale	24.88	3,495	86,956	116,296	Dec 19 06:01 PM
Linetsky David	SVP, Life Sciences	Dec 18 '24	Sale	25.38	24	609	8,851	Dec 19 05:59 PM
Linetsky David	SVP, Life Sciences	Dec 17 '24	Sale	25.06	61	1,529	8,875	Dec 18 08:30 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

PHR

Phreesia Inc

Upgrade your FINVIZ experience